<DOC>
	<DOCNO>NCT02338323</DOCNO>
	<brief_summary>The purpose study determine whether febuxostat benzbromarone could protect renal function , one could better .</brief_summary>
	<brief_title>Compare Renal Protective Effects Febuxostat Benzbromarone</brief_title>
	<detailed_description>Chronic kidney disease patient hyperuricemia glomerular filtration rate ( GFR ) 20-50 ml/min treat febuxostat benzbromarone . Follow change serum uric acid , serum creatinine GFR level . Compare effect renal function two drug .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<mesh_term>Benzbromarone</mesh_term>
	<criteria>Chronic kidney disease patient glomerular filtration rate ( GFR,2050ml/min ) match one follow criterion : 1 . Gout 2 . Hyperuricemia patient without gout cardiovascular risk serum uric acid &gt; 480umol/L 3 . Hyperuricemia patient without gout serum uric acid &gt; 540umol/L 1 . GFR &lt; 20ml/min GFR &gt; 50ml/min 2 . Liver dysfunction ( Aspartate transaminase or/and alanine aminotransferase exceed 2 time normal range ) 3 . Urinary tract obstruction 4. unstable angina , heart failure ( stage IIIIV , NYHA ) , new stroke , need diuretic longterm treatment 5 . Severe lung diseases cancer 6 . Pregnant woman woman prepare pregnant，nursing mother 7. unable sign inform consent form，or disagree followingup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hyperuricemia</keyword>
	<keyword>Renal Function</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Febuxostat</keyword>
	<keyword>Benzbromarone</keyword>
</DOC>